EpidmedX's Seed Round

EpidmedX raised a round of funding on February 03, 2013. Investors include i2E.

EpimedX is a biotechnology company dedicated to finding, patenting, and licensing cures and/or effective treatments for the world's major diseases including sickle cell disease.…

Articles about EpidmedX's Seed Round: